| pubmed-article:11382583 | pubmed:abstractText | The advent of various technologies for middle ear implants (MEI) that directly stimulate the ossicles has created a new therapy for hearing loss and a new segment of the medical device industry. Benefits can be established when the MEI is compared with the best alternative currently available. Otologics, LLC, has developed an electromechanical MEI (middle ear transducer (MET) Ossicular Stimulator) designed to aid individuals with moderately severe to severe sensorineural hearing loss. The efficacy of the device is determined through a clinical comparison of the MET Ossicular Stimulator to that of a state-of-the-art digital hearing aid. | lld:pubmed |
